Source link : https://www.newshealth.biz/health-news/nearly-2000-pharmaceutical-plants-are-overdue-for-fda-checks-after-covid-delays/
Federal regulators responsible for the safety of the U.S. drug supply are still struggling to get back to where they were in 2019, before the COVID-19 pandemic upended factory inspections in the U.S. and across the world, the Associated Press has found. An AP analysis of FDA data shows that agency staffers have not returned […]
Author : News Health
Publish date : 2024-09-05 15:40:58
Copyright for syndicated content belongs to the linked Source.